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Abstract
Unlike most bacterial species, Mycobacterium tuberculosis depends on the Clp proteolysis system for survival even in in vitro
conditions. We hypothesized that Clp is required for the physiologic turnover of mycobacterial proteins whose
accumulation is deleterious to bacterial growth and survival. To identify cellular substrates, we employed quantitative
proteomics and transcriptomics to identify the set of proteins that accumulated upon the loss of functional Clp protease.
Among the set of potential Clp substrates uncovered, we were able to unambiguously identify WhiB1, an essential
transcriptional repressor capable of auto-repression, as a substrate of the mycobacterial Clp protease. Dysregulation of
WhiB1 turnover had a toxic effect that was not rescued by repression of whiB1 transcription. Thus, under normal growth
conditions, Clp protease is the predominant regulatory check on the levels of potentially toxic cellular proteins. Our findings
add to the growing evidence of how post-translational regulation plays a critical role in the regulation of bacterial
physiology.
Citation: Raju RM, Jedrychowski MP, Wei J-R, Pinkham JT, Park AS, et al. (2014) Post-Translational Regulation via Clp Protease Is Critical for Survival of
Mycobacterium tuberculosis. PLoS Pathog 10(3): e1003994. doi:10.1371/journal.ppat.1003994
Editor: Marcel A. Behr, McGill University, Canada
Received May 21, 2013; Accepted January 29, 2014; Published March 6, 2014
Copyright:  2014 Raju et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Bill and Melinda Gates Foundation (OPP1024065 to DS). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: erubin@hsph.harvard.edu
Introduction
Our understanding of how bacteria regulate cellular processes
has long focused on the role of transcription factors in the
modulation of cellular responses. In eukaryotes, however, eluci-
dation of the ubiquitin-proteasome pathway has illustrated that
targeted degradation of functional proteins is often employed as a
regulatory mechanism[1,2]. Like eukaryotes, bacteria possess an
array of compartmentalized proteolytic complexes, capable of
degrading proteins into smaller polypeptides and amino acids[3,4].
Initially, they were thought to maintain protein quality control
through the recognition of misfolded, aberrant protein products.
Several studies identified an array of endogenous proteins that
were targeted for degradation in bacteria[5,6]. While this
suggested an active role of proteolysis in the regulation of bacterial
physiology, it has been difficult to determine the functional
significance of protein degradation by these proteolytic machines
in bacteria.
Mycobacterium tuberculosis (Mtb), the causative agent of tubercu-
losis that kills nearly 1.3 million people annually[7], may provide
unique insights into the importance of targeted protein degrada-
tion in bacteria. In most model prokaryotes, where the compart-
mentalized proteases have been extensively studied, they are
largely dispensable for normal growth[8,9]. However, a genome-
wide screen for essential genes in Mtb suggested that numerous
proteolytic complexes (namely Clp, FtsH, and HtrA) were
absolutely required for cell survival, providing evidence for their
critical role in bacterial physiology[10]. Further studies on the Clp
complex revealed that inhibition or depletion of the protease
results in mycobacterial death both in vitro and in a mouse model of
infection[11,12].
The ATP-dependent Clp proteolytic complex is composed of a
serine proteolytic core that interacts with a set of regulatory
ATPases. In mycobacteria, the ClpP proteolytic core, normally a
homomeric complex in most bacteria, is actually comprised of two
stacked heptameric rings of ClpP1 and ClpP2 multimers [13].
Targeted proteins enter through an axial pore that is regulated by
the interaction of the ClpP1P2 complex with various AAA+
ATPases (ClpC1 and ClpX in Mtb) [14,15], thus forming the full
Clp complex. In Mtb, though endogenous protein substrates have
yet to be identified, Clp has been implicated in the recycling of
abnormal peptides stalled on the ribosome, through recognition of
SsrA-tagged proteins[11].
In this study, we constructed a conditional ClpP1P2 protease
mutant in Mtb and compared the proteomes of ClpP1P2-deficient
cells to wildtype Mtb using recently developed MS3-based isobaric
multiplexed quantitative proteomics. We identified one of the
targets of the Clp protease as WhiB1, an essential transcriptional
repressor that contains an iron-sulfur cluster. Blocking Clp-
dependent degradation of WhiB1 resulted in stabilization of
WhiB1 in mycobacteria. This stabilized allele was functional but
toxic even at physiological levels, suggesting that proteolysis is the
primary regulatory check on the amount of WhiB1 present. These
data establish a mechanism for the essentiality of Clp protease in
PLOS Pathogens | www.plospathogens.org 1 March 2014 | Volume 10 | Issue 3 | e1003994mycobacteria, and provide critical evidence of the dominant role
that protein turnover plays in regulating bacterial physiology.
Results
Clp protease is essential in Mycobacterium tuberculosis
The essentiality of Clp protease has been demonstrated in the
non-pathogenic, fast growing model organism, Mycobacterium
smegmatis (Msm), but not in Mycobacterium tuberculosis (Mtb). We
constructed a Clp protease conditional mutant in Mtb that took
advantage of complementary systems of promoter regulation and
inducible protein degradation, recently developed for use in
mycobacteria (FIGURE 1A). Addition of anhydrotetracycline
(ATc) to this strain, denoted P750-clpP1P2DAS, simultaneously
repressed transcription of the clpP1P2 operon and led to the
degradation of existing ClpP2 protein[16].
At low inoculums (5610
5 CFU/mL), addition of ATc (1.5 mg/
mL) to P750-clpP1P2DAS had a bactericidal effect, demonstrating
that ClpP1 and ClpP2 are essential in Mtb (FIGURE 1B). At
higher inocula (1610
7 CFU/mL), depletion also inhibited growth
(FIGURE S1). These higher inocula allowed us to harvest cellular
material for protein and transcript expression analysis. Production
of SspB resulted in profound depletion of ClpP2-DAS within
48 hours, or two replicative cycles (FIGURE 1C). Furthermore,
qPCR analysis of clpP1 and clpP2 mRNA revealed that by
48 hours, transcription at the clpP1P2 locus was significantly
repressed in cultures exposed to ATc (FIGURE 1D).
Proteomic identification of Clp substrates in
Mycobacterium tuberculosis
The P750-clpP1P2DAS strain enabled us to conditionally
deplete the ClpP1P2 proteolytic core and explore the mechanism
of essentiality of Clp protease in Mtb. We hypothesized that
growth inhibition observed in this strain resulted from an
accumulation of Clp substrates that were either toxic to the cell
or that repressed normal growth. To identify potential substrates,
we utilized LC/MS/MS3-based multiplexed quantitative proteo-
mics with isobaric tandem mass tags (TMT) to quantify and
compare the proteomes of Clp deficient and wildtype Mtb[17].
Briefly, six isobaric TMT (TMT126-131) tags (Thermo Fisher)
have isobaric masses and are used to label the peptides from the
proteomes of six different experimental conditions. When pooled,
the same peptides from all conditions co-elute during fraction-
ation. However, upon isolation and MS3 fragmentation of the
initial single MS peptide peak, the six TMT molecules fragment
differently between the 126–131 mass range. The resultant peak
heights of the TMT ions represent the relative quantities of a given
peptide between the different samples.
We harvested P750-clpP1P2DAS grown from an initial
inoculum of 1610
7 CFU/mL for 48 hours either in the absence
or presence of 1.5 mg/mL ATc, with biological triplicates (a total
of six conditions and proteomic samples). Immunoblot analysis
demonstrated a significant knockdown of ClpP2 in each of the
cultures exposed to ATc (FIGURE 2A). Through TMT labeling
followed by MS3-based quantitative proteomics[18], we quantified
1564 proteins. Hierarchical clustering using Pearson correlational
analysis revealed a strong correlation between the proteomes of
the three biological replicates (FIGURE 2B) [19]. A total of 132
proteins were significantly over-represented in mutant bacteria.
We defined significant over-representation (or under-representa-
tion) as an average change of two-fold or more between mutant
and wildtype conditions, and a p-value of less than or equal to 0.01
across the biological replicates (FIGURE 2C). Gene ontology
(GO) analysis failed to reveal enrichment of any particular GO
class among the over-represented proteins in Clp-depleted
bacteria[20]. However, there were numerous transcriptional
modulators with increased abundance in mutant bacteria (TABLE
S1). Comparing protein intensity values between mutant and
wildtype bacteria revealed a set of proteins that were highly over-
represented (.5-fold increase, 24 proteins), moderately over-
represented (2–5-fold increase, 108 proteins), or under-represented
(.2-fold decrease, 23 proteins) (see examples in FIGURE 2D).
ClpP1 and ClpP2 were the two most under-represented proteins in
the screen, both depleted over 90% in mutant cells compared to
wildtype.
Transcriptional factors WhiB1 and CarD are likely Clp
protease substrates
Protein accumulation upon Clp depletion could be the result of
ineffective proteolysis due to reduced levels of Clp protease, but
may also be due to a transcriptional upregulation of certain stress-
induced proteins as a reaction to Clp depletion. The accumulation
of numerous heat shock proteins suggested that, to some extent,
this was the case. To determine the subset of over-represented
proteins that were likely Clp substrates, we used quantitative PCR
analysis to compare the transcript levels of putative substrates in
Clp-deficient and wildtype bacteria. This analysis revealed three
groups, one where increases in protein abundance upon Clp
depletion could be explained by mRNA abundance, a second
where there was a clear discordance between protein amount and
transcript level change, and a third where the difference was less
clear (FIGURE 3A). We posited that the latter two groups were
more likely to contain Clp substrates, as the changes in protein
abundance were more likely due to protein-level regulation than
transcriptional upregulation.
To further validate potential substrates of the Clp protease, we
turned to a conditional clpP2 mutant (clpP2_ID Msm) we had
previously developed in Msm[11]. In this strain, an analogous
protein degradation system leads to rapid loss of ClpP2 protein.
We previously reported that this mutant allowed for rapid
degradation of ClpP2, and ClpP2 depletion resulted in the
accumulation of a reporter substrate due to decreased turnover.
We performed similar quantitative proteomic and transcriptional
analysis on this strain comparing proteins both with and without
ClpP2 depletion (FIGURE S2, TABLE S2). Proteomic analysis
revealed 107 proteins elevated in the Msm mutant compared to
wildtype Msm, and a 9.3% overlap (n=10 proteins) with the
results from the Mtb screen (TABLE S3). Through our combined
Mtb and Msm analysis, we identified two essential transcriptional
effectors, CarD and WhiB1, with increased protein abundance
Author Summary
To date, studies on the regulation of physiology and
virulence in Mycobacterium tuberculosis (Mtb) have focused
on how transcriptional changes lead to adaptation.
Interestingly, Mtb has numerous proteases that are
essential for normal growth suggesting that protein
turnover may also play an important regulatory role in
the pathogen. We used novel methods to identify the set
of proteins that are degraded by the essential Clp
protease. The degradation of one protein, WhiB1, was
required for normal growth confirming that inhibiting
turnover of certain substrates can have a lethal effect. The
understanding of essential pathways in Mtb will be
important for the discovery of novel drugs to aid in the
global fight against tuberculosis.
Substrates of the Essential Mtb Clp Protease
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and wildtype bacteria.
To assay WhiB1 and CarD degradation by Clp, we constructed
GFP-fusion proteins by adding GFP to either the N- or C-terminus
of each protein, and producing these fusions on an ATc-inducible
promoter. These fusion proteins allowed us both to alter protease
recognition by modifying a potential, terminal recognition se-
quence and follow the accumulation of the resultant protein.
Additionally, by tightly regulating the transcription of these con-
structs on an inducible plasmid, we could prevent transcriptional
modulation from confounding our results. Production in wildtype
Msm revealed differential abundances, as measured by fluores-
cence, between N- and C-terminal fusions for each protein.
(FIGURE 3B, black bars). Despite the differential fluorescence
between the two WhiB1 fusions, quantitative PCR analysis re-
vealed that inducible production of GFP-WhiB1 and WhiB1-GFP
led to similar amounts of transcript in the cell, suggesting that
differential fluorescence observed was regulated at the protein level
(FIGURE S3A).
To demonstrate that this discrepancy was specifically due to Clp
protease, we introduced the fusions into clpP2_ID Msm, where
addition of ATc simultaneously induced production of each fusion
construct and depletion of ClpP2, and assessed protein abundances.
For both WhiB1 and CarD, depletion of ClpP2 resulted in an
increase in the abundance of the N-terminal GFP fusion relative to
wildtype Msm, as measured both by fluorometry and immunoblot
(FIGURE 3B, FIGURE S3B), presumably reflecting stabilization
due to reduced turnover. Several other proteins exhibited different
effects. For both RpL28 and DnaA, C-terminal GFP fusions were
actually less stable than their respective N-terminal constructs. In
the case of RpL28, depletion of ClpP2 stabilized both fusions,
suggesting that the motif for Clp recognition was internal and not
Figure 1. Clp protease is required for normal growth in Mycobacterium tuberculosis. (A) Schematic depicting the construction of a
conditional clpP1P2 mutant (Mtb P750-clpP1P2DAS). A stable, chromosomal merodiploid was first constructed by integrating an additional copy of
the clpP1P2 operon at the L5 site. In this additional operon, the native promoter was replaced with a ATc responsive promoter, and the end of clpP2
was modified by appending a DAS inducible degradation motif. Next, the original clpP1P2 operon was deleted using mycobacterial recombineering.
Lastly, a plasmid bearing ATc-inducible sspB was integrated into the attB site on the chromosome, allowing for inducible degradation of ClpP2-DAS.
(B) Growth curves of Mtb P750-clpP1P2DAS in the presence or absence of ATc (1.5 mg/mL). Data are represented as mean CFU/mL +/2 standard
deviation. (C) Depletion of ClpP2-DAS was tracked over time by immunoblot in wt H37Rv and P750-clpP1P2DAS in the presence or absence of ATc
(1.5 mg/mL). Blots were probed with a-ClpP2 and a-RpoB (loading control). (D) Quantitative PCR to determine clpP1 and clpP2 transcript levels using
RNA generated from Mtb P750-clpP1P2DAS after growth for 48 h in the presence or absence of ATc (1.5 mg/mL). Relative standard curves were
generated for each probe set, and sigA transcript was used as an endogenous control. Data are represented as mean fold change, normalized to
transcript in (2) ATc cultures +/2 SEM of technical replicates.
doi:10.1371/journal.ppat.1003994.g001
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stabilized at all upon ClpP2 depletion suggesting that DnaA was
either not a substrate or that both free ends were required for
proteolysis (FIGURE S4A). From these results, it appears that there
may be numerous recognition motifs that lead to Clp-dependent
degradation. Unfortunately, bioinformatics analysis did not reveal
any common motifs among the proteins identified as putative Clp
substrates in our proteomic screening.
To test whether the C-terminus of WhiB1 was sufficient to confer
destabilization and recognition by Clp protease we constructed a
variety of fusions where a variable number of C-terminal WhiB1
residues were appended to the end of GFP. We found that the
addition of the last fifteen, nine, and five amino acids of WhiB1 to
GFP destabilized the protein with respect to wildtype GFP.
Furthermore, wildtype levels of GFP were restored in these
constructs upon ClpP2 depletion (FIGURE 3C). Similarly, the C-
terminal fifteen residues of CarD destabilized GFP (FIGURES4B).
Stabilization of WhiB1 and blocking Clp-dependent
degradation is toxic in mycobacteria
We noted that prolonged over-production of WhiB1-GFP
inhibited the growth of mycobacteria and led to cell lysis
(FIGURE 4A and 4B). This effect appeared to be specific to
the C-terminal GFP fusion. To determine if the protein was still
functional, and toxicity was not due to a non-specific effect, we
determined if the WhiB1 fusion, as has been previously shown
with wildtype WhiB1[21], could act as an auto-repressor. We used
RT-PCR to determine transcription of the native protein in its
normal chromosomal location, and found that the fusion protein
was still able to serve as a repressor (FIGURE 4C). To further test
the functionality of the WhiB1-GFP allele, we built a more
sensitive reporter of promoter activity by fusing the putative whiB1
promoter to luciferase. By introducing this construct into strains
inducibly producing the GFP fusions, we could simultaneously
monitor fluorescence for protein abundance and stability and
Figure 2. Proteomic profiling of P750-clpP1P2DAS in the presence and absence of ATc reveals a wide array of potential Clp
protease substrates. (A) In triplicate, P750-clpP1P2DAS was grown for 48 hours in the absence, denoted ‘‘wt’’, or presence of ATc (1.5 mg/mL),
denoted ‘‘mut’’, from a starting OD600 of 0.02. Immunoblotting of protein lysates with a-ClpP2 and a-RpoB (loading control) demonstrates degree of
ClpP2-DAS depletion in mut cells. Samples were then used for TMT6 MS3-based quantitative proteomics. The specific TMT reagent used for each
condition is listed under the immunoblot. (B) Normalized, summed intensities for all quantified proteins was used to perform Pearson correlational
hierarchical clustering of biological replicates. (C) The Log2 ratio of average mutant protein intensity to average wildtype protein intensity plotted
against the p-value determined by t-test, grouping the three biological replicates. The threshold for over-representation was set at an average ratio of
greater than equal to 2, while the cut-off for under-representation was 0.5. In both instances, p-values below 0.01 were deemed significant. Proteins
considered for further analysis are denoted in red. (D) The relative quantity of specific proteins plotted across the six TMT channels, for highly (left)
and moderately (center) over-represented, and under-represented (right) proteins in the mutant versus wildtype conditions.
doi:10.1371/journal.ppat.1003994.g002
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amount of repression appeared to correlate inversely with the
amount of fusion protein present (FIGURE 4D). These observa-
tions suggest that the toxicity observed for WhiB1-GFP could be
due to increased protein abundance, a result of stabilization from
lack of recognition of the blocked C-terminus by Clp protease.
In all of the above experiments, the fusion whiB1 constructs were
expressed on multi-copy plasmids, perhaps leading to dramatic
overexpression. To test if physiological levels of the degradation-
deficient WhiB1 protein would be lethal, we constructed integrative
plasmids with the native whiB1 promoter upstream of each fusion
gene. This construct would lead to physiological levels of WhiB1
under natively regulated conditions. Transformation of these
plasmids into Msm resulted in significantly lower transformation
efficiencies for the plasmid bearing WhiB1-GFP compared to those
with GFP-WhiB1 and WhiB1wt (FIGURE 4E). Colonies
that resulted from WhiB1-GFP transformations plasmid were
significantly smaller and took nearly twice as long to be seen than
the GFP-WhiB1 or control WhiB1wt transformants. This suggests a
considerable fitness cost associated with even a single copy of the
stabilized allele is regulated by the native promoter.
Discussion
Clp proteases have two primary functions. Like other degrada-
tive proteases, they play a role in protein quality control,
degrading improperly synthesized or folded proteins. Indeed, this
does appear to be the case in mycobacteria[11]. However, Clp
proteases in other species also play an important regulatory role in
degrading endogenous proteins. In other bacteria, identifying such
Clp substrates has been facilitated by the use of in vitro systems in
which Clp components have been inactivated so that binding
could be assayed in the absence of proteolysis[22]. Thus far, due to
the heteromeric composition of Clp in Mtb and its stringent
Figure 3. Validation of proteomic hits reveals that WhiB1 and CarD are likely Clp protease substrates. (A) Quantitative PCR to
determine transcript levels of over-represented proteins upon depletion of Clp protease using RNA generated from Mtb P750-clpP1P2DAS after
growth for 48 h in the presence or absence of ATc (1.5 mg/mL). Relative standard curves were generated for each probe set, and sigA transcript was
used as an endogenous control. Data are represented as mean fold change, normalized to transcript in (2) ATc cultures +/2 SEM of technical
replicates. Protein ratios are derived from TMT experiments described in Figure 2, and represented as average ratios +/2 standard deviation of
biological replicates (B) Fluorescence (485/538) was measured for N- and C-terminal GFP fusions constructed for WhiB1 (left) and CarD (right), and
induced for 8 hours in wildtype or clpP2-ID Msm with ATc (100 ng/mL). In clpP2-ID, ATc simultaneously induced fusion protein production and
degradation of ClpP2. (C) Fluorescence (485/538) was measured for GFP fusions bearing a variable number of C-terminal residues from WhiB1 in
clpP2-ID Msm, grown in the absence or presence of ATc (100 ng/mL) for 8 hours. In (B) and (C), data are represented as mean RFU +/2 standard
deviation of biological replicates. Asterisks denote a p-value ,0.05 determined by t-test.
doi:10.1371/journal.ppat.1003994.g003
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analogous approach. Instead, we relied on an in vivo assay for the
accumulation of substrates taking advantage of recently developed,
highly accurate proteomic methods. This approach is somewhat
problematic as depleting Clp is quite toxic and it can be difficult to
disentangle protein accumulation due to cellular responses from
that resulting from lack of proteolysis of direct substrates.
Nevertheless, using a combination of transcriptional analysis and
sequence modifications to alter protein recognition, we were able
to unambiguously define some new Clp protease substrates.
Alternative approaches to identifying ClpP substrates have been
highly successful. For example, using an inactive ClpP mutant in
Staphylococcus aureus, Feng, et al., [23] were able to affinity purify
substrates. Unfortunately, despite many attempts, we were unable
to use this method in mycobacteria. And, since protein abundance
can be regulated both by transcription and degradation, using
transcriptional regulation to screen for likely substrates will
exclude some actual substrate proteins. For example, while CarD
is not transcriptionally upregulated in Msm, it is mildly
upregulated in Mtb; yet, we find that it is a substrate.
Thus far, using any approach has not clearly identified strong
consensus sequences for degradation. In E. coli, the N end rule
governs degradation of some substrates[24] others have conserved
C terminal di-alanines[22] but most have none. Certainly, among
the proteins we have found to be potential substrates we cannot
identify a consensus.
Comparing degradation in two different mycobacterial species
helps provide some additional confidence in recognized substrates.
Although we used different regulatory approaches to deplete
proteolytic subunits, we expect to have a good deal of biological
Figure 4. Blocking Clp-dependent degradation of WhiB1 is toxic in mycobacteria. (A) Inducible production of GFP-WhiB1, WhiB1-GFP, and
WhiB1wt in Msm demonstrates growth inhibition of WhiB1-GFP producing bacteria. Over-production was induced with ATc (100 ng/mL). (B) Growth
curves of strains producing WhiB1 constructs in the presence of ATc (100 ng/mL). As a control, strains producing WhiB1wt were grown in the absence
of inducer. Data are represented as mean OD600 +/2 standard deviation of biological replicates. (C) Quantitative PCR, using probe sets that hybridize
to the whiB1 59utr, to determine transcriptional repression at the endogenous whiB1 locus in wildtype Msm, or Msm inducibly expressing gfp-whiB1
or whiB1-gfp. RNA was isolated from cultures grown for 6 hours from a starting OD600 of 0.06 in the presence of the inducer ATc (100 ng/mL). Relative
standard curves were generated for each probe set, and sigA transcript was used as an endogenous control. Data are represented as mean fold
change, normalized to transcript in wildtype cultures +/2 SEM of technical replicates. (D) Promoter reporters were constructed fusing the 500 bp
upstream of whiB1 to luciferase. Luminescence (RLU, 100 ms exposure, grey bars) was measured in wildtype Msm, or Msm inducibly producing GFP-
WhiB1 or WhiB1-GFP. Amounts of the fusion proteins were monitored by fluorescence (RFU, 485/538, black bars). Data are represented as RFU or RLU
+/2 standard deviation of biological replicates. (E) GFP whiB1 fusions and wildtype whiB1 were cloned into integrative plasmids, in which expression
was driven by the native whiB1 promoter. Constructs were transformed into Msm, and transformation efficiency was determined by calculating
colony forming units (CFU) obtained per ng DNA. In (C), (D), and (E), asterisks denote a p-value ,0.05, determined by t-test.
doi:10.1371/journal.ppat.1003994.g004
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to occur[11]. Depleting either or both should have similar effects.
Our results suggest that there are significant similarities among
substrates and, for example, both WhiB1 and CarD can be
degraded by Clp in both species.
Do these results help us to understand why Clp is essential for
bacterial growth and survival? Certainly, altering the sequence of
WhiB1 so that it is no longer easily degraded results in cellular
toxicity. Even when this stabilized allele is expressed at physiologic
levels, it appears to be quite toxic. Thus, part of the function of Clp
is to degrade the WhiB1 protein and keep its levels in check. This
is reminiscent of the situation in Caulobacter crescentus, one of the few
bacteria where Clp protease is also essential. In this organism,
degradation of CtrA by Clp is absolutely necessary for the
transition of a non-replicating, motile swarmer cell into a
replicating, stalked cell[25], and loss of Clp protease activity
results in cellular growth arrest. In mycobacteria, we can further
establish the importance of post-translational regulation in
prokaryotes by showing that WhiB1 levels are coordinated by a
mixture of transcriptional and protein-level regulation, but that it
is the interruption of protein-level regulation through Clp
inhibition that is essential.
Why could the turnover of WhiB1 be required for normal
growth? In mycobacteria, WhiB proteins are capable of binding
redox-sensitive [4Fe-4S] clusters, which can serve as redox-active
co-factors or as switches that reflect the reductive and oxidative
potential of a cell[26]. The WhiB proteins may be disulfide
reductases[27], but are certainly transcription factors capable of
modulating cellular processes that are intimately tied to the redox
state of the cell or perceived oxidative stress[28]. In Mtb, WhiB1 is
an essential DNA binding protein capable of auto-repressing its
own transcription[21]. ChIP-Seq to determine the WhiB1 regulon
in Mtb has been undertaken, and preliminary data suggests the
presence of 71 binding sites for WhiB1, thirteen of which are
essential[29]. Accumulation of WhiB1 might repress at several
sites resulting in the lack of synthesis of critical metabolites such as
heme and riboflavin. Alternatively, supraphysiologic levels of
WhiB1, due to absence of turnover, may result in binding of the
transcription factor to low affinity sites with repression of other
essential genes.
Does stabilization of WhiB1 account for all of the essentiality of
Clp? Several lines of evidence suggest that this is unlikely to be true.
Clp is the primary proteolysis system for degrading SsrA-tagged
proteins, which result from trans-translation due to ribosomal
stalling[30]. We have found that the small RNA, tmRNA, required
for producing this tag, is itself essential[31]. In fact, this trans-
translation system is at least one of the targets of the antimyco-
bacterial drug pyrazinamide[32]. Loss of Clp would result in
accumulation of these tagged proteins. Moreover, not only are the
ClpP1 and ClpP2 protease subunits required for optimal in vitro
growth but two of the alternate adapter proteins, ClpX and ClpC1
are essential as well. The fact that both these adapters are required
supports the hypothesis that there are multiple substrates that need
to be recognized (at least one per ATPase) by Clp protease to
facilitate normal growth. For example, it is interesting to note that
CarD has been implicated in the stringent response, and directly
interacts with the beta-subunit of the RNA polymerase to down
regulate transcription of the translational machinery and amino
acid biosynthetic enzymes[33]. While stabilization of CarD alone is
not sufficient to cause toxicity in mycobacteria, the transcriptional
repression of enzymes important for vegetative growth facilitated by
CarD may contribute to the growth inhibition observed upon
depletion of Clp protease, and partially explain the essentiality of
Clp protease in mycobacteria.
Transcriptional regulation plays a critical role in bacterial
adaptation to new environments. However, much of regulation is
likely to be post-transcriptional and no less important for bacterial
survival. In the case of WhiB1, M. tuberculosis employs both
transcriptional and post-transcriptional (Clp-mediated proteolysis)
forms of regulation. Clearly, protein degradation mediated by Clp is
required even in the absence of clear environmental stressors.
Identifying the substrates for the Clp protease and other essential
degradative proteases will help move us towards a more holistic
understanding of how bacteria coordinate critical cellular activities
through the integration of transcriptional and proteolytic regulation.
Materials and Methods
Bacterial strains and plasmids
Msm mc
2155 (Msm) or Mtb H37Rv were grown at 37uCi n
Middlebrook 7H9 broth with 0.05% Tween 80 and ADC (0.5%
BSA, 0.2% dextrose, 0.085% NaCl, 0.003 g catalase/1 L media).
Mtb was additionally supplemented with oleic acid (0.006%). For
growth curves, overnight cultures were diluted into the appropri-
ate media and growth was either measured by OD600 or colony
forming units per mL. A complete list of plasmids and primers
used in this study can be found in TABLE S4 and TABLE S5.
Detailed procedures on strain construction can be found in the
Supplemental Experimental Procedures.
Fluorescence and luminescence measurements
In order to measure the abundance of GFP fusion proteins,
cultures within one experiment were normalized based on OD600
values, spun down to remove media, and resuspended in 100 mLo f
PBSina clearbottom96wellplate.Forluminescence,cultureswere
normalized based on OD600 values, and 150 mL of culture was used
for measuring luciferase activity. 50 mL of Cell Culture 5X Lysis
Reagent (Promega) was added to cultures, and samples were
agitated for 10 min on an orbital shaker, at room temperature.
Next, 75 mL of Luciferase Assay Substrate (Promega) was added to
each sample and directly taken for measurement. Fluorescence was
measured at 485/538 nm, and luminescence was measured at an
exposure time of 10 milliseconds, by the Fluroskan Ascent FL plate
reader (ThermoScientific). Results represent the median +/2
standard deviation of biological replicates.
Quantitative PCR
In Mtb and Msm, RNA was generated from equivalent of
20 mLs of cells at OD600 0.5. Cultures were spun down, and
subjected to bead beating (3X 45 sec each, 5 min on ice between
pulses) after resuspension in TRIzol. After chloroform phase
separation, genetic material was precipitated with isopropanol,
resuspended in dH2O, and RNA was purified using RNeasy Mini
Kit (Qiagen). To ensure no contamination from genomic DNA,
purified RNA was subjected to an additional round of DNase
digestion using the TURBO DNA-free Kit (Invitrogen). cDNA
was created from isolated equal concentrations of RNA with the
SuperScript III First Strand Synthesis System (Invitrogen).
Quantitative PCR was performed with the SYBR FAST qPCR
kit (KapaBiosystems) using the Applied Biosystems 7500 Fast Real-
Time PCR System. All experiments were done using biological
replicates, and representative experiments are depicted +/2
standard error of mean of technical replicates.
Sample preparation, protein digestion, and peptide TMT
labeling
For Mtb proteomics, P750-clpP1P2DAS was diluted to a
starting OD600 0.02 in 900 mLs of 7H9 media. This culture was
Substrates of the Essential Mtb Clp Protease
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three batches, while three were left to grow without induction.
After 48 hours, cultures were spun down (10 min, 4000 rpm, 4uC)
and washed 3X with PBS. Cultures were then resuspended in
1 mL Urea Lysis Buffer (8 M urea in 50 mM Tris pH 8.2, 75 mM
NaCl, 50 mM NaF, 50 mM b-glycerophosphate, 1 mM Na
orthovanadate, Roche Complete EDTA-free Protease Inhibitor
Cocktail tablets), and subjected to bead beating (3X 45 sec each,
5 min on ice between pulses). Cell lysates were spun down
(10 min, 13,000 rpm, 4uC), and samples were reduced with DTT
(final concentration of 5 mM) for 30 min at 37uC and cooled to
room temp for 15 minutes. Samples were then alkylated with
iodoacetamide (final concentration of 14 mM) for 30 min at room
temperature in the dark. Adding an additional 5 mM DTT and
incubating samples at room temperature in the dark for 15 min
quenched excess iodoacetamide. To remove samples from the
BL3-level facility, proteins were precipitated with 20% trichlor-
oacetic acid and incubated on ice for a hour. Proteins were
pelleted by centrifugation (30 min, 13,000 rpm, 4uC), and pellets
were washed twice with acetone. Samples were resuspended in
8 M urea containing 50 mM TRIS pH 8.5, diluted, and protein
amounts were quantified using a BCA assay (ThermoScientific).
As the proteomics screen in Msm was performed prior to the
development of MS3-based proteomics for TMT analysis, we
performed MS2-based quantitation of TMT peptide signals. For
Msm proteomics, Msm/pTet(OR)::HIV2pr and clpP2_ID Msm
were diluted to a starting OD600 0.05 in 450 mLs. ATc (100 ng/
mL) was added to each strain, and cultures were divided into
150 mL batches. Samples were harvested at 0 h, 5 h, and 11 h
post addition of ATc, spun down (10 min, 4000 rpm, 4uC), and
washed 3X with PBS. Protein samples were prepared in a similar
fashion as above, except no TCA precipitation was needed, and
protein quantitation by the BCA assay was done prior to sample
reduction and alkylation.
Proteins isolated from Mtb and Msm were digested overnight
with Lys-C (Wako) in a 1:100 enzyme:protein ratio in 4 M urea
and 50 mM Tris-HCl (pH 8.2). Digests were acidified with formic
acid to a pH of ,2–3, and subjected to C18 solid-phase extraction
(Sep-Pak, Waters). Isobaric labeling of the peptides was accom-
plished with sixplex TMT reagents (Thermo Scientific). Reagents
(0.8 mg) were dissolved in 40 ml acetonitrile, and 20 ml of the
solution was added to 200 mg of peptides dissolved in 100 mlo f
50 mM HEPES (pH 8.5). After 1 h at room temperature, the
reaction was quenched by adding 8 ml of 5% hydroxylamine for
15 minutes. Half of each of the labeled reactions was pooled into
one vial, acidified with formic acid, diluted ACN to 5% final
volume and subjected to C18 solid-phase extraction. Details on
sample fractionation, liquid chromatography electrospray ioniza-
tion tandem mass spectrometry, and data processing/analysis can
be found in the Supplemental Experimental Procedures.
Supporting Information
Figure S1 Depletion of Clp protease in Mtb P750-
clpP1P2DAS. Growth curves of Mtb P750-clpP1P2DAS in the
presence or absence of ATc (1.5 mg/mL) starting at a high initial
inoculum (1610
7 CFU/mL). Higher inoculums facilitated protein
and RNA extraction for proteomic and qPCR analysis, respec-
tively. Data are represented as mean OD600 +/2 standard
deviation.
(PDF)
Figure S2 Proteomic profiling of clpP2-ID Msm in the
presence and absence of ATc reveals a set of potential
Clp protease substrates. (A) clpP2-ID Msm was grown in the
presence or absence of ATc (100 ng/mL) from a starting OD600 of
0.04 for 5 or 11 hours. Depletion of ClpP2-ID was tracked by
immunoblot of protein lysates, probing for a-myc and a-RpoB
(loading control). Samples were then used for TMT6 MS2-based
quantitative proteomics. The specific TMT reagent used for each
condition is listed under the immunoblot. (B) Normalized, median
intensities for all quantified proteins was used to perform Perason
correlational hierarchical clustering of the different conditions. (C)
The Log2 ratios of median protein intensity at 5 h for ClpP2
depleted cells (mut) to ClpP2 containing cells (wt). The threshold
for over-representation was set at an average ratio of greater than
or equal to 2, while the cut-off for under-representation was less
than or equal to 0.5. Hits are denoted in red. (D) For a given set of
proteins, the ratio of mutant to wildtype protein at 5 hours was
compared to the ratio of transcript levels. Quantitative PCR was
employed to determine transcript levels using RNA generated
from clpP2-ID Msm after growth for 5 h in the presence or
absence of ATc (100 ng/mL). Relative standard curves were
generated for each probe set, and sigA transcript was used as an
endogenous control. For each target, data are represented as mean
fold change, of mutant cells normalized to wildtype transcript
amount +/2 SEM of technical replicates.
(PDF)
Figure S3 Overproduction of WhiB1 fusion constructs
(GFP-WhiB1 and WhiB1-GFP) confirmed by quantitative
PCR and immunoblot. (A) Quantitative PCR using a probe set
that hybridized to both chromosomal and episomal copy of whiB1
to determine transcript abundance of whiB1 in strains inducibly
over-expressing gfp-whiB1 and whiB1-gfp, compared to wildtype
Msm. RNA was isolated from cultures grown for 6 hours from a
starting OD600 of 0.06 in the presence of the inducer ATc
(100 ng/mL). Relative standard curves were generated for each
probe set, and sigA transcript was used as an endogenous control.
Data are represented as mean fold change, normalized to
transcript in wildtype cultures +/2 SEM of technical replicates.
(B) Wildtype (wt) and clpP2-ID Msm inducibly producing WhiB1
GFP fusion proteins were grown in the presence ATc (100 ng/mL)
from a starting OD600 of 0.04 for 9 hours to induce production of
the fusion proteins. In the case of clpP12-ID, ATc simultaneously
resulted in depletion of ClpP2. Accumulation of fusion proteins
and depletion of ClpP2 were monitored by immunoblot using a-
GFP and a-ClpP2, respectively.
(PDF)
Figure S4 Characterization of DnaA, RpL28 as potential
substrates of Clp protease, and localization of CarD
degron. (A) N- and C-terminal GFP-fusions for DnaA and
RpL28, identified as potential Clp substrates from proteomic
profiling of clpP2-ID Msm. Fluorescence (485/538) was measured
for N- and C-terminal GFP fusions constructed for DnaA (left) and
RpL28 (right), and induced for 8 hours in wildtype or clpP2-ID
Msm with ATc (100 ng/mL). In clpP2-ID, ATc simultaneously
induced fusion protein production and degradation of ClpP2. (B)
Fluorescence (485/538) was measured for wildtype GFP, and GFP
fusions bearing either the N-terminal C-terminal 15 amino acids
from CarD. The constructs were expressed on a constitutive,
episomal plasmid in wildtype Msm. In both (A) and (B), data are
represented as mean RFU +/2 standard deviation of biological
replicates. Asterisks denote a p-value ,0.05 determined by t-test.
(PDF)
Table S1 Complete list of proteins identified through
quantitative proteomic profiling of P750-clpP1P2DAS
Mtb in the presence and absence of ATc. List of all proteins
identified through proteomic profiling of P750-clpP1P2DAS Mtb
Substrates of the Essential Mtb Clp Protease
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data included: NCBI protein accession number, Rv number,
Protein definition, Number of peptides identified, Normalized
summed TMT intensity for wildtype replicates (Reporter ions 126,
127, 128), Normalized summed TMT intensity for Clp depleted
replicates (Reporter ions 129, 130, 131), Average wildtype reporter
ion intensity, Average mutant reporter ion intensity, mutant:wild-
type ratio, and p-value (as determined by unpaired t-test grouping
wildtype and mutant replicates).
(XLSX)
Table S2 Complete list of proteins identified through
quantitative proteomic profiling of clpP2-ID Msm in the
presence and absence of ATc. List of all proteins identified
through quantitative proteomic profiling of clpP2-ID Msm in the
presence and absence of ATc with the following data included:
NCBI protein accession number, Protein definition, Number
peptides identified, Normalized median TMT intensity for wild-
type Msm at 0 h (Reporter ion 126), 5 h (Reporter ion 127), 11 h
(Reporter ion 128), Normalized median TMT intensity for
Clp depleted strain at 0 h (Reporter ion 129), 5 h (Reporter ion
130), 11 h (Reporter ion 131), Mutant:wildtype ratio at 0 h,
Mutant:wildtype ratio at 5 h, and Mutant:wildtype ratio at 11 h.
(XLSX)
Table S3 List of orthologous proteins in Mtb and Msm
found through proteomic screening for Clp protease
substrates. Potential Clp substrates identified through Mtb and
Msm screens were cross-referenced and 10 orthologous proteins
were identified as potential Clp substrates in both species.
Potential substrates in Mtb were defined as proteins that showed
a greater than two-fold over-abundance in Clp-depleted strains
compared to wildtype strains, with a p-value of less than 0.01 as
measured by t-test grouping replicates. Potential substrates in Msm
were defined as proteins that showed no difference prior to Clp
depletion, but then showed a greater than two-fold overabundance
in the Clp-depleted strain compared to the wildtype strain after
5 hours of depletion.
(XLSX)
Table S4 Plasmids used in this study. All plasmids used for
experiments are listed, with specific references to particular
plasmids included in the Supplementary Methods S1.
(DOC)
Table S5 Primers used in this study. All primers used for
strain construction and qPCR are listed, with specific references to
particular primers included in the Supplementary Methods S1.
(DOC)
Methods S1 Supplementary Methods S1 includes fur-
ther information on (1) Bacterial strains and plasmids,
(2) Sample fractionation by high pH reverse phase and
strong cation exchange chromatography, (3) Liquid
chromatography electrospray ionization tandem mass
spectrometry, and (4) Data processing: MS2 spectra
assignment, data filtering and quantitative data analy-
sis.
(DOC)
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